Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 2, single-arm, open-label, multicenter study analyzing molecular response of P1101 in patients with Polycythemia Vera and Elevated Hematocrit

Next Previous
Trial Profile

A phase 2, single-arm, open-label, multicenter study analyzing molecular response of P1101 in patients with Polycythemia Vera and Elevated Hematocrit

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 12 Dec 2023 Results (n=95) if updated analysis of P1101 Therapy in patients with Polycythemia Vera and Elevated Hematocrit presented at the 65th American Society of Hematology Annual Meeting and Exposition
  • 02 Nov 2023 According to PharmaEssentia media release, data from this study will be presented at the 65th American Society of Hematology (ASH) Annual Meeting
  • 02 Feb 2023 Results presented in a PharmaEssentia Corporation Media Release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top